Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen M Mowry

Showing results (51-60 of 163) with videos related to

Pageof 17
Sort By:
Multiple Sclerosis and Related Disorders|January 19, 2025
Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centersDevon S Conway, Jacqueline A Nicholas, Nicolas R Thompson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2024
Structural MRI measures are associated with fatigue severity and persistence in a large, real-world cohort of people with multiple sclerosisAlexandra C Simpson, Chen Hu, Ellen M Mowry, et al.
Journal of the Neurological Sciences|October 1, 2020
Reliability and validity of the multiple sclerosis resiliency scale (MSRS)Abbey J Hughes, Krina Patel, Kathryn C Fitzgerald, et al.
AJR. American Journal of Roentgenology|May 3, 2017
Follow-Up of Emergency Department MRI Scans Suggesting New Diagnosis of CNS DemyelinationJina Pakpoor, Deanna Saylor, Izlem Izbudak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2019
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatmentJeffrey A Cohen, Maria Trojano, Ellen M Mowry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 2, 2026
Quantifying observable movement reserve in multiple sclerosis via upper diurnal activity quantilesPratim Guha Niyogi, Muraleetharan Sanjayan, Rahul Ghosal, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis opticaJennifer Graves, Uma Vinayagasundaram, Ellen M Mowry, et al.
Multiple Sclerosis and Related Disorders|January 29, 2019
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomesKathryn C Fitzgerald, Amber Salter, Tuula Tyry, et al.
Multiple Sclerosis and Related Disorders|May 5, 2024
Relevance of antinuclear antibody in diagnosis and characteristics of multiple sclerosisJacqueline Koshorek, Chen Hu, Yujie Wang, et al.
Multiple Sclerosis and Related Disorders|November 2, 2018
Multiple sclerosis relapse: Qualitative findings from clinician and patient interviewsLouis S Matza, Katherine Kim, Glenn Phillips, et al.
Pageof 17

Showing results (51-60 of 163) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis and Related Disorders|January 19, 2025
Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centersDevon S Conway, Jacqueline A Nicholas, Nicolas R Thompson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2024
Structural MRI measures are associated with fatigue severity and persistence in a large, real-world cohort of people with multiple sclerosisAlexandra C Simpson, Chen Hu, Ellen M Mowry, et al.
Journal of the Neurological Sciences|October 1, 2020
Reliability and validity of the multiple sclerosis resiliency scale (MSRS)Abbey J Hughes, Krina Patel, Kathryn C Fitzgerald, et al.
AJR. American Journal of Roentgenology|May 3, 2017
Follow-Up of Emergency Department MRI Scans Suggesting New Diagnosis of CNS DemyelinationJina Pakpoor, Deanna Saylor, Izlem Izbudak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2019
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatmentJeffrey A Cohen, Maria Trojano, Ellen M Mowry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 2, 2026
Quantifying observable movement reserve in multiple sclerosis via upper diurnal activity quantilesPratim Guha Niyogi, Muraleetharan Sanjayan, Rahul Ghosal, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis opticaJennifer Graves, Uma Vinayagasundaram, Ellen M Mowry, et al.
Multiple Sclerosis and Related Disorders|January 29, 2019
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomesKathryn C Fitzgerald, Amber Salter, Tuula Tyry, et al.
Multiple Sclerosis and Related Disorders|May 5, 2024
Relevance of antinuclear antibody in diagnosis and characteristics of multiple sclerosisJacqueline Koshorek, Chen Hu, Yujie Wang, et al.
Multiple Sclerosis and Related Disorders|November 2, 2018
Multiple sclerosis relapse: Qualitative findings from clinician and patient interviewsLouis S Matza, Katherine Kim, Glenn Phillips, et al.
Pageof 17